Albumin Taxol — Competitive Intelligence Brief

Albumin Taxol (Albumin Taxol) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Taxane; microtubule stabilizer. Area: Oncology.

phase 3 Taxane; microtubule stabilizer β-tubulin Oncology Small molecule

Target snapshot

Albumin Taxol (Albumin Taxol) — Fujian Medical University. Albumin-bound paclitaxel (nab-paclitaxel) stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and halting cell division.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Albumin Taxol TARGET	Albumin Taxol	Fujian Medical University	phase 3	Taxane; microtubule stabilizer	β-tubulin
''albendazole'' and ''ivermectin''	''albendazole'' and ''ivermectin''	Centre d'Appui à la lutte contre la Maladie	marketed	Antihelmintic/Antiparasitic agents	β-tubulin (albendazole); glutamate-gated chloride channels (ivermectin)
Docetaxel or albumin paclitaxel	Docetaxel or albumin paclitaxel	Shandong Cancer Hospital and Institute	marketed	Taxane; microtubule-stabilizing chemotherapy agent	β-tubulin (microtubule)
Administration of Albendazole on Day 1	Administration of Albendazole on Day 1	London School of Hygiene and Tropical Medicine	marketed	Benzimidazole anthelmintic	β-tubulin
ZENTEL and Vitamin A Soft Capsules	ZENTEL and Vitamin A Soft Capsules	Chengdu Maternal and Children's Health Care Hospital	marketed	Anthelmintic + Vitamin supplement	β-tubulin (albendazole component)
Docetaxel (DOC)	Docetaxel (DOC)	Sun Yat-sen University	marketed	Taxane; microtubule stabilizer	β-tubulin
Paclitaxel (albumin-bound)	Paclitaxel (albumin-bound)	Dai, Guanghai	marketed	Taxane; microtubule stabilizer	β-tubulin (microtubule)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Taxane; microtubule stabilizer class)

1. Sanofi · 2 drugs in this class
2. Aravive, Inc. · 1 drug in this class
3. Athenex, Inc. · 1 drug in this class
4. Barts & The London NHS Trust · 1 drug in this class
5. BeyondSpring Pharmaceuticals Inc. · 1 drug in this class
6. Bio-Thera Solutions · 1 drug in this class
7. Dai, Guanghai · 1 drug in this class
8. Fujian Medical University · 1 drug in this class
9. Guangzhou Double Bioproducts Co., Ltd · 1 drug in this class
10. H. Lee Moffitt Cancer Center and Research Institute · 1 drug in this class